MEDOVEX CORP. WARRANT AGENCY AGREEMENTWarrant Agency Agreement • July 8th, 2014 • Medovex Corp. • Surgical & medical instruments & apparatus • New York
WARRANT AGENCY AGREEMENT made as of June __, 2014 (the “Issuance Date”), between Medovex Corp., a Nevada corporation, with offices at 3279 Hardee Avenue, Atlanta, Georgia 30341 (“Company”), and Interwest Transfer Company, Inc., with offices at 1981 Murray Holladay Road, Suite 100, Salt Lake City, UT 84117 (“Warrant Agent”).
MEDOVEX, INC. _______ Units, each consisting of One Share of Common Stock, $0.001 par value and One Warrant to Purchase One Share of Common Stock, $0.001 par value, and Class B Warrants FORM OF UNDERWRITING AGREEMENTMedovex Corp. • July 8th, 2014 • Surgical & medical instruments & apparatus • Florida
Medovex, Inc., a Nevada corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the several underwriters (the “Underwriters”) named on Schedule I hereto for whom you are acting as representative (the “Representative”), an aggregate of [___________] units (the “Underwritten Units”) and ______ Class B Warrants (the “Underwritten Series B Warrants”) of the Company’s securities. The Company has granted the Underwriters the option to purchase an aggregate of up to ___________ additional units (the “Additional Units” and collectively with the Underwritten Units, the “Units”) and ____ additional Series B Warrants (the “Additional Series B Warrants” and collectively, with Underwritten Series B Warrants the “Series B Warrants”) each as may be necessary to cover over-allotments made in connection with the offering. Each Unit consists of one share of the Company’s common stock, par value $0.001 per share (the “Common Stock”), and one warrant
